Stocks · News reference
Filed: 2026-08-12 AccNo: 0001493152-26-037254 Size: 787 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
ENvue Medical (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced it has been selected to
ENvue Medical (NASDAQ: FEED) announced a 1-for-12 reverse stock split effective September 1, 2026, reducing outstanding shares from approximately 11.1 million to 923,718 shares. The split was approved by the board and stockholders on August 14, 2026, and will not impact stockholder ownership percentages or voting rights. The company will continue trading under the symbol 'FEED' with a new CUSIP number.
ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split of the Company’s issued and outstanding common